Marketing company Amway will offer PerioPredict by Interleukin Genetics to its U.S. employees.
The periodontal disease risk test will become available to about 5,000 Amway employees in September as part of a new employee benefits plan. Employees will also be able to use Interleukin's patient engagement platform that provides personalized content.